NYMX Insider Trading Activity and SEC Form 4 Filings
NYMX insider trading summary
No open-market insider purchases or sales of Nymox Pharmaceutical Corp (NYMX) have been reported on SEC Form 4 in the past 12 months.
Latest NYMX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 2, 2022 | James George Robinson | Insider | Buy | $1.9M (1,151,515 @ $1.65) |
| Apr 22, 2021 | James George Robinson | Director | Buy | $7K (3,100 @ $2.10) |
| Apr 22, 2021 | James George Robinson | Director | Buy | $10K (4,949 @ $2.09) |
| Apr 22, 2021 | James George Robinson | Director | Buy | $106 (51 @ $2.08) |
| Apr 22, 2021 | James George Robinson | Director | Buy | $14K (7,000 @ $2.07) |
| Apr 22, 2021 | James George Robinson | Director | Buy | $10K (5,000 @ $2.05) |
| Apr 22, 2021 | James George Robinson | Director | Buy | $6K (2,900 @ $2.09) |
| Apr 22, 2021 | James George Robinson | Director | Buy | $4K (1,900 @ $2.13) |
| Apr 22, 2021 | James George Robinson | Director | Buy | $2K (1,100 @ $2.09) |
| Apr 22, 2021 | James George Robinson | Director | Buy | $2K (800 @ $2.10) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.